Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2007, p. 3004-3007, Vol. 51, No. 8
0066-4804/07/$08.00+0 doi:10.1128/AAC.00167-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Sequencing and Comparative Genomic Analysis of pK29, a 269-Kilobase Conjugative Plasmid Encoding CMY-8 and CTX-M-3 ß-Lactamases in Klebsiella pneumoniae
Ying-Tsong Chen,1*
Tsai-Ling Lauderdale,2
Tsai-Lien Liao,1
Yih-Ru Shiau,2
Hung-Yu Shu,3
Keh-Ming Wu,1,4
Jing-Jou Yan,5
Ih-Jen Su,2 and
Shih-Feng Tsai1,3,4,6,7
Division of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Miaoli, Taiwan,1
Division of Clinical Research, National Health Research Institutes, Zhunan, Miaoli, Taiwan,2
Genome Research Center, National Yang-Ming University, Taipei, Taiwan,3
Institute of Bioinformatics, National Yang-Ming University, Taipei, Taiwan,4
Department of Pathology, National Cheng Kung University Hospital, Tainan, Taiwan,5
Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei, Taiwan,6
Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan7
Received 5 February 2007/
Returned for modification 25 March 2007/
Accepted 19 May 2007

ABSTRACT
A 269-kilobase conjugative plasmid, pK29, from a
Klebsiella pneumoniae strain was sequenced. The plasmid harbors multiple
antimicrobial resistance genes, including those encoding CMY-8
AmpC-type and CTX-M-3 extended-spectrum ß-lactamases
in the common backbone of IncHI2 plasmids. Mechanisms for dissemination
of the resistance genes are highlighted in comparative genomic
analyses.

TEXT
Plasmid-mediated ß-lactamases play a key role in the
increasing multidrug resistance in the
Enterobacteriaceae worldwide,
among which CTX-M-type extended-spectrum ß-lactamases
(ESBLs) and AmpC-type ß-lactamases are two major contributors
in recent years (
3,
14,
17,
19). In general, ESBLs confer resistance
to oxyimino-cephalosporins but not cephamycins and are inhibited
by ß-lactamase inhibitors, while AmpC-type ß-lactamases
provide resistance to cephamycins and oxyimino-cephalosporins
and are refractory to ß-lactamase inhibitors. Although
reports of multiple ß-lactamases in a single pathogen
are increasing for the
Enterobacteriaceae, especially
Klebsiella pneumoniae (
1,
9,
15,
22,
26), the complete sequence information
for a plasmid that encodes both an ESBL and an AmpC-type ß-lactamase
has not been reported.
In Taiwan, CTX-M- and SHV-type ESBLs and CMY- and DHA-type AmpC-type enzymes are the most common ß-lactamases that can confer resistance to extended-spectrum cephalosporins in clinical K. pneumoniae isolates (24, 26). Here we report the sequencing, annotation, and comparative genomic analysis of an IncHI2 plasmid isolated from a nosocomial K. pneumoniae strain. The plasmid carries both CTX-M- and CMY-type ß-lactamase genes.
Three K. pneumoniae isolates from three patients were collected from the National Cheng Kung University Hospital in Taiwan during a 1-month period in 2001. These three isolates shared identical antimicrobial susceptibility and plasmid profiles (data not shown). Conjugal transfer was performed by using one of the K. pneumoniae isolates, NK29, as the donor and Escherichia coli J53 Azir as the recipient, following a previously described protocol (11). Transconjugants were obtained at an efficiency of 10–4 to 10–5 transconjugants/donor at 25°C. DNA sequencing of the plasmid was determined as part of the process of sequencing the entire genome of K. pneumoniae NK29, using a shotgun approach. Sequence assembly, annotation, and analysis followed previously described protocols (4).
The plasmid pK29 was determined to be a 269,674-bp circular plasmid with a G+C content of 46%. A total of 310 open reading frames (ORFs) were identified. Since pK29 carries the backbone of the IncHI2 plasmids, we compared its nucleotide sequence with those of pR478 and pAPEC-O1-R, the IncHI2 plasmids with complete nucleotide sequences available to date. Plasmid pR478 (275 kb) was from Serratia marcescens clinical isolates, and plasmid pAPEC-O1-R (241 kb) was from avian pathogenic E. coli strains (6, 12).
The common regions of the three plasmids contain essential genes for plasmid replication, maintenance, and transmission. These include the repHIA and repHI2 regions for replication initiation, the trh and tra genes for conjugation, and the par region for plasmid segregation (Fig. 1).
Two antimicrobial resistance gene-containing regions (Fig.
1,
regions 1 and 2) are unique to pK29. Region 1 (bp 94,051 to
115,352) encodes HipBA multidrug tolerance protein homologs
(
13) and carries a type I integron containing the antimicrobial
resistance gene cassettes
aadA2,
aac (putative), and
catB2 (Fig.
2). In the integron region, the inverted repeat IRt was identified
at the right end of IS
6100 but the IRi was not found. The integron
is flanked by two complete IS
26 elements. In addition, a partial
duplicate of the 3'-conserved sequence of the integron, including
the
qacEdelta1 and
sul-1 genes, was identified on the left of
the integron, followed by an AmpC ß-lactamase gene,
blaCMY-8. No
intl1 or gene cassettes were found on the left
of the duplicate 3'-conserved sequence.
The AmpC ß-lactamase
blaCMY-8 was first identified
in a 25-kb plasmid of a
K. pneumoniae epidemic strain from southern
Taiwan (
25). The originally determined 1,973-bp spanning sequence
of
blaCMY-8 (GenBank accession no. AF167990), which contains
part of the upstream
orf513 and the downstream hypothetical
ORF, can be aligned perfectly to that of pK29. The association
of
blaCMY-8 with
orf513 (recently renamed insertion sequence
common regions [IS
CR1]) (
23) indicates that the
blaCMY-8 gene
is mobilized with these type I integron-associated elements.
In pK29, an additional IS
26 element was identified at the left
end of
orf513 (Fig.
2). Thus, the
blaCMY-8 region and the nearby
type I integron region represent two small composite transposon-like
elements, and the entire 14-kb region bounded by the two external
IS
26 elements could also be regarded as a large composite transposon
(Fig.
2). We did not, however, find direct repeats or other
supportive evidence for the transpositional acquisition of any
of these putative composite transposons. The insertion sequences
likely contributed to the formation of the region as a result
of multiple transposition and recombination events.
Region 2 (bp 208,636 to 230,024) contains a lacIZY gene cluster followed by several IS-related conserved hypothetical genes and a 3.8-kb putative composite transposon. This contains a blaCTX-M-3 ESBL gene flanked by two convergently positioned ISEcp1 elements at both ends, with that on the left being truncated (Fig. 2).
The CTX-M-3 ESBL was first found among clinical Enterobacteriaceae isolates from Warsaw (7) and, soon after, from Taiwan (27). The finding of identical CTX-M enzymes in widely separated parts of the world has been suggested to be the result of independent evolution (17). However, the blaCTX-M-3 genes of both pK29 and pCTX-M-3, the plasmid from Poland (GenBank accession no. AF550415), were found to reside in a 3-kb homologous region with >99% identity, including a 1,656-bp ISEcp1 element upstream of the ß-lactamase gene. Recent studies on the frequent association of blaCTX-M and ISEcp1-like insertion sequences have demonstrated that the IS may be responsible for the mobilization and expression of the ß-lactamase gene (20, 21). Thus, the presence of blaCTX-M-3 in different geographical regions is likely to be the consequence of horizontal transmission assisted by the nearby ISEcp1 element.
The plasmid pK29 carries both hipBA and relEB homologs. Known as type II toxin-antitoxin modules, the products of these genes are important in the segregation maintenance of plasmids (8, 10). Recently, some of them have been suggested to play a role in the formation of persister cells that exhibit multidrug tolerance (13). pK29 also carries a mucAB operon for mutagenesis (16). By facilitating the formation of persister cells and enhancing the mutation rate, these genes may provide additional advantages to bacterial survival in the presence of lethal factors such as antibiotics.
The transconjugant E. coli J53/pK29 revealed resistance or decreased susceptibilities to cefotaxime, cefoxitin, ceftriaxone, amoxicillin-clavulanic acid, aztreonam, ceftazidime, cefepime, chloramphenicol, and sulfamethoxazole (Table 1). The resistance phenotype is consistent with the resistance genes identified on the plasmid. Both NK29 and the J53/pK29 transconjugant tested negative for ESBL by the CLSI ESBL confirmatory disk diffusion test (5), likely due to the presence of the AmpC ß-lactamases. Thus, the coexistence of ESBL and AmpC ß-lactamases not only limits treatment options but also complicates routine phenotypic detection of ESBLs, a problem of increasing concern for clinical microbiology laboratories (2, 17, 18).
View this table:
[in this window]
[in a new window]
|
TABLE 1. MICs of different antimicrobials and ESBL test results for the clinical strain K. pneumoniae NK29, its plasmid pK29 transconjugant E. coli J53/pK29, and the reference strain E. coli J53
|
This is the first report of a completely sequenced plasmid that
carries both CTX-M-type ESBL and CMY-type AmpC ß-lactamase
genes. The finding of the coexistence of these genes in such
a transmissible plasmid that can propagate in different hosts
provides further insight into the mechanisms of transmission
of these ß-lactamases in Taiwan, where plasmid-mediated
ESBLs and AmpC ß-lactamases are prevalent.
Nucleotide sequence accession number.
The annotated sequence of pK29 has been submitted to the GenBank nucleotide sequence database under accession number EF382672.

ACKNOWLEDGMENTS
We thank George A. Jacoby, Lahey Clinic, Massachusetts, for
providing the
E. coli J53 Azi
r strain.
This project was funded by a grant from the National Science Council (NSC-95-3112-B-400-011) and by an intramural grant from the National Health Research Institutes (CL-095-PP-01).

FOOTNOTES
* Corresponding author. Mailing address: Division of Molecular and Genomic Medicine, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 350, Taiwan. Phone: 886-37246166, ext. 35345. Fax: 886-37586459. E-mail:
onion{at}nhri.org.tw 
Published ahead of print on 25 May 2007. 

REFERENCES
1 - Alvarez, M., J. H. Tran, N. Chow, and G. A. Jacoby. 2004. Epidemiology of conjugative plasmid-mediated AmpC ß-lactamases in the United States. Antimicrob. Agents Chemother. 48:533-537.[Abstract/Free Full Text]
2 - Black, J. A., E. S. Moland, and K. T. Thomson. 2005. AmpC disk test for detection of plasmid-mediated AmpC ß-lactamases in Enterobacteriaceae lacking chromosomal AmpC ß-lactamases. J. Clin. Microbiol. 43:3110-3113.[Abstract/Free Full Text]
3 - Bonnet, R. 2004. Growing group of extended-spectrum ß-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.[Free Full Text]
4 - Chen, Y. T., H. Y. Hsu, L. H. Li, T. L. Liao, K. M. Wu, Y. R. Shiau, J. J. Yan, I. J. Su, S. F. Tsai, and T. L. Lauderdale. 2006. Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum-beta-lactamase activity in a clinical Klebsiella pneumoniae isolate. Antimicrob. Agents Chemother. 50:3861-3866.[Abstract/Free Full Text]
5 - Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests. Approved standard, 9th ed. Document M2-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
6 - Gilmour, M. W., N. R. Thomson, M. Sanders, J. Parkhill, and D. E. Taylor. 2004. The complete nucleotide sequence of the resistance plasmid R478: defining the backbone components of incompatibility group H conjugative plasmids through comparative genomics. Plasmid 52:182-202.[CrossRef][Medline]
7 - Gniadkowski, M., I. Schneider, A. Palucha, R. Jungwirth, B. Mikiewicz, and A. Bauernfeind. 1998. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing ß-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob. Agents Chemother. 42:827-832.[Abstract/Free Full Text]
8 - Gotfredsen, M., and K. Gerdes. 1998. The Escherichia coli relBE genes belong to a new toxin-antitoxin gene family. Mol. Microbiol. 29:1065-1076.[CrossRef][Medline]
9 - Hanson, N. D., K. S. Thomson, E. S. Moland, C. C. Sanders, G. Berthold, and R. G. Penn. 1999. Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC. J. Antimicrob. Chemother. 44:377-380.[Abstract/Free Full Text]
10 - Hayes, F. 2003. Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science 301:1496-1499.[Abstract/Free Full Text]
11 - Jacoby, G. A., and P. Han. 1996. Detection of extended-spectrum ß-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 34:908-911.[Abstract]
12 - Johnson, T. J., Y. M. Wannemeuhler, J. A. Scaccianoce, S. J. Johnson, and K. L. Nolan. 2006. Complete DNA sequence, comparative genomics, and prevalence of an IncHI2 plasmid occurring among extraintestinal pathogenic Escherichia coli isolates. Antimicrob. Agents Chemother. 50:3929-3933.[Abstract/Free Full Text]
13 - Keren, I., D. Shah, A. Spoering, N. Kaldalu, and K. Lewis. 2004. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172-8180.[Abstract/Free Full Text]
14 - Livermore, D. M., and N. Woodford. 2006. The ß-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14:413-420.[CrossRef][Medline]
15 - Moland, E. S., S. G. Hong, K. S. Thomson, D. H. Larone, and N. D. Hanson. 2007. Klebsiella pneumoniae isolate producing at least eight different ß-lactamases, including AmpC and KPC ß-lactamases. Antimicrob. Agents Chemother. 51:800-801.[Free Full Text]
16 - Mortelmans, K. 2006. Isolation of plasmid pKM101 in the Stocker laboratory. Mutat. Res. 612:151-164.[CrossRef][Medline]
17 - Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectrum beta-lactamase: a clinical update. Clin. Microbiol. Rev. 18:657-686.[Abstract/Free Full Text]
18 - Pfaller, M. A., and J. Segreti. 2006. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin. Infect. Dis. 42:S153-S163.[CrossRef][Medline]
19 - Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type ß-lactamases. Antimicrob. Agents Chemother. 46:1-11.[Free Full Text]
20 - Poirel, L., J. W. Decousser, and P. Nordmann. 2003. Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M ß-lactamase gene. Antimicrob. Agents Chemother. 47:2938-2945.[Abstract/Free Full Text]
21 - Poirel, L., M. F. Lartigue, J. W. Decousser, and P. Nordmann. 2005. ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli. Antimicrob. Agents Chemother. 49:447-450.[Abstract/Free Full Text]
22 - Song, W., K. M. Lee, H. S. Kim, J. S. Kim, J. Kim, S. H. Jeong, and K. H. Roh. 2006. Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 ß-lactamase at a burns intensive care unit. Int. J. Antimicrob. Agents. 28:520-524.[CrossRef][Medline]
23 - Toleman, M. A., P. M. Bennett, and T. R. Walsh. 2006. ISCR elements: novel gene-capturing systems of the 21st century? Microbiol. Mol. Biol. Rev. 70:296-316.[Abstract/Free Full Text]
24 - Yan, J. J., P. R. Hsueh, J. J. Lu, F. Y. Chang, J. M. Shyr, J. H. Wan, Y. C. Liu, Y. C. Chuang, Y. C. Yang, S. M. Tsao, H. H. Wu, L. S. Wang, T. P. Lin, H. M. Wu, H. M. Chen, and J. J. Wu. 2006. Extended-spectrum ß-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob. Agents Chemother. 50:1861-1864.[Abstract/Free Full Text]
25 - Yan, J. J., S. M. Wu, S. H. Tsai, J. J. Wu, and I. J. Su. 2000. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum ß-lactamases and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan. Antimicrob. Agents Chemother. 44:1438-1442.[Abstract/Free Full Text]
26 - Yan, J. J., W. C. Ko, H. M. Wu, S. H. Tsai, C. L. Chuang, and J. J. Wu. 2004. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. J. Clin. Microbiol. 42:5337-5340.[Abstract/Free Full Text]
27 - Yan, J. J., W. C. Ko, S. H. Tsai, H. M. Wu, Y. T. Jin, and J. J. Wu. 2000. Dissemination of CTX-M-3 and CMY-2 ß-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J. Clin. Microbiol. 38:4320-4325.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, August 2007, p. 3004-3007, Vol. 51, No. 8
0066-4804/07/$08.00+0 doi:10.1128/AAC.00167-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Carattoli, A.
(2009). Resistance Plasmid Families in Enterobacteriaceae. Antimicrob. Agents Chemother.
53: 2227-2238
[Full Text]
-
Paauw, A., Caspers, M. P. M., Leverstein-van Hall, M. A., Schuren, F. H. J., Montijn, R. C., Verhoef, J., Fluit, A. C.
(2009). Identification of resistance and virulence factors in an epidemic Enterobacter hormaechei outbreak strain. Microbiology
155: 1478-1488
[Abstract]
[Full Text]
-
Chen, Y.-T., Liao, T.-L., Liu, Y.-M., Lauderdale, T.-L., Yan, J.-J., Tsai, S.-F.
(2009). Mobilization of qnrB2 and ISCR1 in Plasmids. Antimicrob. Agents Chemother.
53: 1235-1237
[Abstract]
[Full Text]
-
Jacoby, G. A.
(2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev.
22: 161-182
[Abstract]
[Full Text]